ArticleFrontiers in psychiatry2026
Management algorithm for alcohol withdrawal syndrome, alcohol dependence (AD) and AD with anxiety in the Indian population: a narrative review with expert opinion.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comments on "Effectiveness of Binaural Beats in Reducing Anxiety in Alcohol Withdrawal Patients: A Single-group Pre-post Interventional Study".Indian journal of psychological medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alcohol dependence (AD) is associated with several physical and psychiatric implications such as those observed in alcohol withdrawal syndrome (AWS) and AD with co-morbid anxiety. With the increasing burden of AD in India, both physicians and psychiatrists face unique challenges while managing patients with AWS, AD, and AD with anxiety. Physicians are often the first point of contact for patients presenting with alcohol use-related medical complications but lack clear management directives that distinguish their role from that of psychiatrists. To address this need gap, a series of five focus group discussions were conducted with a total of 57 expert physicians and psychiatrists. The expert opinions are presented along with supporting evidence from current literature based on a comprehensive literature review. This practice and policy review presents guidance for physicians and psychiatrists on the optimal screening, diagnosis, and treatment pathways to follow for patients presenting with each of the three indications. It highlights the importance of accurately diagnosing and distinguishing the three indications by using distinct inventories of presenting symptoms, questions to be asked as a part of comprehensive history-taking of the patient, screening questionnaires and tools, and laboratory investigations. It also discusses the roles of different classes of drugs in addressing the diverse presentations and comorbidities associated with each indication. Benzodiazepines, especially long-acting ones like chlordiazepoxide, remain the mainstay for detoxification protocols for both AWS and AD. Physicians need to work in conjunction with psychiatrists and refer the patient when required, based on distinct criteria such as severity of psychiatric comorbidities, complications of withdrawal, and behavioral issues leading to persistent alcohol use and relapses. The application of this holistic management approach that encompasses the multifaceted nature of alcohol-use related disorders will help reduce relapse rates and ensure optimal patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.